Tesamorelin/Ipa research peptide vial

tesa ipa blend 13 3 mg ruo

Tesamorelin / Ipamorelin Blend 13/3mg | Research Use Only | Pep TideZ 808
PepTideZ 808
Research Use Only

TideZ of Discovery

Tesamorelin / Ipamorelin Blend 13/3mg

Synergistic research blend for advanced growth hormone axis studies. Lyophilized Tesamorelin / Ipamorelin 13/3mg supplied for laboratory use only. Third-party tested. Batch COA and endotoxin report included. Not for human or animal consumption, injection, or any clinical use.

$99.00
13 mg Tesamorelin + 3 mg Ipamorelin · lyophilized
Label claim Tesamorelin 13 mg / Ipamorelin 3 mg
Assayed total 14.99 mg · 99.10% total purity
Documentation Third-party COA + endotoxin page included
Endotoxin 0.31 EU/mg · Pass (limit 35 EU/mg)
Request this research material
RESEARCH USE ONLY. This material is sold strictly for in-vitro laboratory research, analytical method development, and other non-clinical scientific applications. It is not a drug, supplement, or cosmetic. It has not been evaluated by the FDA. No statements on this page are dosing guidance or claims of safety or efficacy for human use.

What is in the vial

Blend composition

One sealed glass vial labeled Tesamorelin/Ipamorelin Blend 13/3mg. Label claim is Tesamorelin 13 mg and Ipamorelin 3 mg. Third-party assay on this batch measured 11.71 mg tesamorelin and 3.28 mg ipamorelin (14.99 mg total).

Identity on the label

Brand: Pep TideZ 808. Product: Tesamorelin/Ipamorelin Blend. Strength callout: 13/3mg. Vertical mark: RESEARCH USE ONLY. Vial lot mark: 808-PTSN / PTDZ-04.

Intended research context

Research combination of the stabilized GHRH analog Tesamorelin with the selective growth hormone secretagogue Ipamorelin. Intended for laboratory studies examining synergistic effects on GH-axis signaling pathways. Not supplied for personal administration.

Molecular identity

Reference structures for the two labeled components. Use these fields for catalog framing, COA matching, and laboratory documentation. For Research Use Only. Not for human consumption.

Tesamorelin component

Role. Stabilized 44-amino-acid GHRH analog with N-terminal modification.

Sequence. Trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂

Molecular formula. C221H366N72O67S

Molecular weight. ≈ 5135–5136 Da

Ipamorelin component

Role. Selective growth hormone secretagogue (GHS).

Sequence. Aib-His-D-2-Nal-D-Phe-Lys-NH₂

Molecular formula. C38H49N9O5

Molecular weight. ≈ 711.9 Da

Blend framing: research combination of Tesamorelin and Ipamorelin for laboratory studies of GH-axis signaling. Sequence and mass values are identity references for the named components; assayed milligram content for this batch is reported in the COA table below.

Purity, COA & endotoxin documentation

Figures below are taken from the third-party Certificate of Analysis and endotoxin page for this Tesa/IPA 13/3 batch. Supplier identity is redacted on customer-facing copies.

Test Method / source Result Status
Total purity Peptide panel (TM-13) 99.10% Reported
Tesamorelin content mg/unit on COA 11.71 mg/unit Reported
Ipamorelin content mg/unit on COA 3.28 mg/unit Reported
Total peptide mass Sum of analytes 14.99 mg/unit Reported
Endotoxin LAL · limit 35.00 EU/mg 0.31 EU/mg Pass
Matrix / presentation COA header Peptide · vial As reported

Matching batch COA and endotoxin pages ship with the vial. Supplier identity is redacted for their protection. Unredacted laboratory identifiers are available to qualified research purchasers upon request.

Label claim remains 13 mg / 3 mg; assayed mass on this batch is 11.71 mg / 3.28 mg. The laboratory header lists sample type as “Vial (Injectable).” That is the lab’s matrix field only. This product is sold as Research Use Only and is not offered for injection or any human use.

COA page 1 — purity

99.10% total purity. Tesamorelin 11.71 mg. Ipamorelin 3.28 mg. Total 14.99 mg.

Certificate of Analysis page 1 showing 99.10% total purity for Tesa/IPA 13/3

COA page 2 — endotoxin

0.31 EU/mg against a 35.00 EU/mg limit. Status: Pass.

Certificate of Analysis page 2 endotoxin result 0.31 EU/mg Pass

Shipping from Honolulu

Protected pack-out

Insulated packaging with ice packs as standard for this lyophilized research material. Discrete, trackable U.S. shipping from Oahu.

Threshold

Free shipping on qualifying orders of $100 or more, consistent with the current Pep TideZ 808 store policy.

Documents in the box

Vial, RUO labeling, and the matching COA / endotoxin report for the shipped batch, with supplier identity redacted.

Research buyer FAQ

Is this for human use?

No. All Pep TideZ 808 products are Research Use Only. They are not intended for human or animal consumption, injection, diagnostic use, therapeutic use, or any form of personal administration.

Who may purchase?

Purchasers must be at least 21 and represent that they are a qualified researcher, laboratory professional, or authorized representative of a legitimate research organization, and that the material will be used only for lawful laboratory research.

What testing is provided?

This batch: 99.10% total purity, 14.99 mg combined peptide, endotoxin 0.31 EU/mg (Pass, limit 35 EU/mg). A redacted two-page COA ships with the vial. Unredacted identifiers are available upon request to qualified research purchasers.

Pep TideZ 808, Honolulu, Hawaii. All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion. These products have not been evaluated by the U.S. Food and Drug Administration. Nothing on this page constitutes medical advice or dosing guidance.